One study indicated that PrPC was highly expressed in consensus molecular subgroup (CMS4), a subtype of CRC with higher malignancy, and affected the prognosis of CRC as an upstream molecule in the PrPC-ILK-IDO1 axis (89). The gene discussed is IDO1; the disease is colorectal carcinoma.